2023
Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials
Smith A, DiMartino L, Garcia S, Mitchell S, Ruddy K, Smith J, Wong S, Cahue S, Cella D, Jensen R, Hassett M, Hodgdon C, Kroner B, Osarogiagbon R, Popovic J, Richardson K, Schrag D, Cheville A, Cella D, Cheville A, Hassett M, Osarogiagbon R, Schrag D, Wong S, Kroner B, Smith A, DiMartino L, Garcia S, Griffin J, Jensen R, Mitchell S, Ruddy K, Smith J, Yanez B, Bian J, Dizon D, Hazard-Jenkins H, Ardini M, Ahrens P, Austin J, Barrett F, Bass M, Begnoche M, Cahue S, Caron K, Chlan L, Coughlin A, Cronin C, Dias S, Farisiv N, Flores A, Garcia M, Hemming K, Herrin J, Hodgdon C, Kircher S, Kroenke K, Lam V, Lancki N, H Q, Mallow J, McCleary N, Norton W, O'Connor M, Pachman D, Pearsonil L, Penedo F, Podratz J, Popovic J, Preiss L, Rahman P, Redmond S, Reich J, Richardson J, Richardson K, Ridgeway J, Rutten L, Schaepe K, Scholtens D, Poirier-Shelton T, Silberman P, Simpson J, Tasker L, Tesch N, Tofthagen C, Tramontano A, Tyndall B, Uno H, Wehbe F, Weiner B. Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials. JNCI Cancer Spectrum 2023, 7: pkad073. PMID: 37930033, PMCID: PMC10627528, DOI: 10.1093/jncics/pkad073.Peer-Reviewed Original ResearchConceptsSymptom management systemManagement of symptomsEffectiveness-implementation trialPhases of careHealth care needsElectronic health record platformsQuality of lifeHealth record platformsSymptom managementImplementation trialHealthcare needsTreatment ConsortiumStudy designSymptomsDeleterious symptomsHybrid effectivenessRecord platformCOVID-19 pandemicContext of disruptionTrialsHospitalizationCancerCare
2014
A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation
Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, Goodacre S, Herrin J, Kerse N, McKinlay RJ, Wright A, Soumerai SB. A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation. Journal Of Clinical Epidemiology 2014, 68: 324-333. PMID: 25499983, DOI: 10.1016/j.jclinepi.2014.10.003.Peer-Reviewed Original ResearchConceptsC-RCTsControl groupInterrupted time series studyConfidence intervalsConcurrent control groupHealth system interventionsHealth system evaluationControl arm dataInterrupted time series designIntervention armRandomized trialsControl group dataTrial dataTime-series studyTime series designHealth systemStudy designEffect estimatesTrialsInterventionSystem interventionsArm dataGroup dataRCTsGroup